Arkolith/Insider Trading/HRMY/Form 4

Kapadia Sandip

CHIEF FINANCIAL OFFICERHarmony Biosciences Holdings, Inc. (HRMY) · full profile →Form 4 · filed Oct 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 30, 2025Option exercise(M)45K—$045K
Sep 30, 2025Tax withholding(F)24K$27.56$663K21K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 30, 2025Option exercise(M)45K—$045K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001677141-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML